|
1
|
Weiss SW and Goldblum JR: Enzinger and
Weiss's Soft Tissue Tumors. 30. 5th. Mosby Elsevier; Philadelphia,
PA: 2008
|
|
2
|
Fletcher CDM, Bridge JA, Hogendoorn P and
Mertens F: WHO Classification of Tumours of Soft Tissue and Bone.
4th. IARC Press; 2013
|
|
3
|
Haldar M, Hancock JD, Coffin CM, Lessnick
SL and Capecchi MR: A conditional mouse model of synovial sarcoma:
Insights into a myogenic origin. Cancer Cell. 11:375–388. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:pp. 15178–15183. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu P, Clanton DJ, Snipas TS, Lee J,
Mitchell E, Nguyen ML, Hare E and Peach RJ: Characterization of a
subpopulation of colon cancer cells with stem cell-like properties.
Int J Cancer. 124:1312–1321. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeimet AG, Reimer D, Sopper S, Boesch M,
Martowicz A, Roessler J, Wiedemair AM, Rumpold H, Untergasser G,
Concin N, et al: Ovarian cancer stem cells. Neoplasma. 59:747–755.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Walter D, Satheesha S, Albrecht P,
Bornhauser BC, D'Alessandro V, Oesch SM, Rehrauer H, Leuschner I,
Koscielniak E, Gengler C, et al: CWS Study Group: CD133 positive
embryonal rhabdomyosarcoma stem-like cell population is enriched in
rhabdospheres. PLoS One. 6:e195062011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mutsaers AJ and Walkley CR: Cells of
origin in osteosarcoma: Mesenchymal stem cells or osteoblast
committed cells? Bone. 62:56–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu A, Feng B, Gu W, Cheng X, Tong T,
Zhang H and Hu Y: The CD133+ subpopulation of the SW982
human synovial sarcoma cell line exhibits cancer stem-like
characteristics. Int J Oncol. 42:1399–1407. 2013.PubMed/NCBI
|
|
13
|
Kekarainen T, Mannelin S, Laine J and
Jaatinen T: Optimization of immunomagnetic separation for cord
blood-derived hematopoietic stem cells. BMC Cell Biol. 7:302006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schieker M, Pautke C, Haasters F, Schieker
J, Docheva D, Böcker W, Guelkan H, Neth P, Jochum M and Mutschler
W: Human mesenchymal stem cells at the single-cell level:
Simultaneous seven-colour immunofluorescence. J Anat. 210:592–599.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Méndez-Ferrer S, Michurina TV, Ferraro F,
Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A,
Enikolopov GN and Frenette PS: Mesenchymal and haematopoietic stem
cells form a unique bone marrow niche. Nature. 466:829–834. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Clark J, Rocques PJ, Crew AJ, Gill S,
Shipley J, Chan AM, Gusterson BA and Cooper CS: Identification of
novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2)
translocation found in human synovial sarcoma. Nat Genet.
7:502–508. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ladanyi M: Fusions of the SYT and SSX
genes in synovial sarcoma. Oncogene. 20:5755–5762. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boman BM and Wicha MS: Cancer stem cells:
A step toward the cure. J Clin Oncol. 26:2795–2799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung Y, Bauer G and Nolta JA: Concise
review: Induced pluripotent stem cell-derived mesenchymal stem
cells: progress toward safe clinical products. Stem Cells.
30:42–47. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sadikovic B, Graham C, Ho M, Zielenska M
and Somers GR: Immunohistochemical expression and cluster analysis
of mesenchymal and neural stem cell-associated proteins in
pediatric soft tissue sarcomas. Pediatr Dev Pathol. 14:259–272.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Santagata S, Ligon KL and Hornick JL:
Embryonic stem cell transcription factor signatures in the
diagnosis of primary and metastatic germ cell tumors. Am J Surg
Pathol. 31:836–845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ben-Porath I, Thomson MW, Carey VJ, Ge R,
Bell GW, Regev A and Weinberg RA: An embryonic stem cell-like gene
expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 40:499–507. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Passegué E: Hematopoietic stem cells,
leukemic stem cells and chronic myelogenous leukemia. Cell Cycle.
4:266–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakanishi M, Niidome T, Matsuda S, Akaike
A, Kihara T and Sugimoto H: Microglia-derived interleukin-6 and
leukaemia inhibitory factor promote astrocytic differentiation of
neural stem/progenitor cells. Eur J Neurosci. 25:649–658. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Terry J and Nielsen T: Expression of CD133
in synovial sarcoma. Appl Immunohistochem Mol Morphol. 18:159–165.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okamoto H, Fujishima F, Nakamura Y,
Zuguchi M, Ozawa Y, Takahashi Y, Miyata G, Kamei T, Nakano T,
Taniyama Y, et al: Significance of CD133 expression in esophageal
squamous cell carcinoma. World J Surg Oncol. 11:512013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang D, Sun B, Zhao X, Ma Y, Ji R, Gu Q,
Dong X, Li J, Liu F, Jia X, et al: Twist1 expression induced by
sunitinib accelerates tumor cell vasculogenic mimicry by increasing
the population of CD133+ cells in triple-negative breast
cancer. Mol Cancer. 13:2072014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bouvier C, Bertucci F, Métellus P, Finetti
P, de Paula A Maues, Forest F, Mokhtari K, Miquel C, Birnbaum D,
Vasiljevic A, et al: ALDH1 is an immunohistochemical diagnostic
marker for solitary fibrous tumours and haemangiopericytomas of the
meninges emerging from gene profiling study. Acta Neuropathol
Commun. 1:102013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
England DM, Hochholzer L and McCarthy MJ:
Localized benign and malignant fibrous tumors of the pleura. A
clinicopathologic review of 223 cases. Am J Surg Pathol.
13:640–658. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Lv DL, Duan JJ, Xu SL, Zhang JF,
Yang XJ, Zhang X, Cui YH, Bian XW and Yu SC: ALDH1A1 expression
correlates with clinicopathologic features and poor prognosis of
breast cancer patients: A systematic review and meta-analysis. BMC
Cancer. 14:4442014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuroda T, Hirohashi Y, Torigoe T, Yasuda
K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M,
et al: ALDH1-high ovarian cancer stem-like cells can be isolated
from serous and clear cell adenocarcinoma cells, and ALDH1 high
expression is associated with poor prognosis. PLoS One.
8:e651582013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsika A, Srinivasan B, Day C, Mader SA,
Kiernan DM, Broomfield A, Fu J, Hooper JD, Kench JG and Samaratunga
H: Cancer stem cell markers in prostate cancer: An
immunohistochemical study of ALDH1, SOX2 and EZH2. Pathology.
47:622–628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nishida S, Hirohashi Y, Torigoe T, Inoue
R, Kitamura H, Tanaka T, Takahashi A, Asanuma H, Masumori N,
Tsukamoto T, et al: Prostate cancer stem-like
cells/cancer-initiating cells have an autocrine system of
hepatocyte growth factor. Cancer Sci. 104:431–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ieni A and Tuccari G: Comments on the
‘Prognostic impact and clinicopathological correlation of CD133 and
ALDH1 expression in invasive breast cancer’. J Breast Cancer.
19:96–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vassilopoulos A, Chisholm C, Lahusen T,
Zheng H and Deng CX: A critical role of CD29 and CD49f in mediating
metastasis for cancer-initiating cells isolated from a
Brca1-associated mouse model of breast cancer. Oncogene.
33:5477–5482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naka N, Takenaka S, Araki N, Miwa T,
Hashimoto N, Yoshioka K, Joyama S, Hamada K, Tsukamoto Y, Tomita Y,
et al: Synovial sarcoma is a stem cell malignancy. Stem Cells.
28:1119–1131. 2010.PubMed/NCBI
|
|
38
|
Brett D, Whitehouse S, Antonson P, Shipley
J, Cooper C and Goodwin G: The SYT protein involved in the t(X;18)
synovial sarcoma translocation is a transcriptional activator
localised in nuclear bodies. Hum Mol Genet. 6:1559–1564. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hayakawa K, Ikeya M, Fukuta M, Woltjen K,
Tamaki S, Takahara N, Kato T Jr, Sato S, Otsuka T and Toguchida J:
Identification of target genes of synovial sarcoma-associated
fusion oncoprotein using human pluripotent stem cells. Biochem
Biophys Res Commun. 432:713–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cironi L, Provero P, Riggi N, Janiszewska
M, Suva D, Suva ML, Kindler V and Stamenkovic I: Epigenetic
features of human mesenchymal stem cells determine their
permissiveness for induction of relevant transcriptional changes by
SYT-SSX1. PLoS One. 4:e79042009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Garcia CB, Shaffer CM, Alfaro MP, Smith
AL, Sun J, Zhao Z, Young PP, VanSaun MN and Eid JE: Reprogramming
of mesenchymal stem cells by the synovial sarcoma-associated
oncogene SYT-SSX2. Oncogene. 31:2323–2334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Saito T: The SYT-SSX fusion protein and
histological epithelial differentiation in synovial sarcoma:
Relationship with extracellular matrix remodeling. Int J Clin Exp
Pathol. 6:2272–2279. 2013.PubMed/NCBI
|
